#United Kingdom #Edinburgh #Bioinformatics #Fios Genomics #Excelra

Fios Genomics Bioinformatics Team Joins Excelra

In a significant development within the scientific computing landscape, Excelra has officially announced the integration of Fios Genomics Ltd's bioinformatics team and services as of October 20, 2026. Based in Edinburgh, Fios Genomics has built a reputation over the last two decades for transforming complex omics data into actionable insights for researchers across the pharmaceutical, biotechnology, and life sciences sectors.

The merging of the two entities marks a strategic enhancement of Excelra’s scientific advisory board. With expertise in multi-omics analysis, the Fios team will continue servicing their existing clientele while leveraging the extensive resources and data-driven capabilities that Excelra offers. According to Sarah Lynagh, CEO of Fios Genomics, the move is intended to ensure continuity in operations and to significantly enhance the support provided to their clients. She remarked, "Fios has always been distinguished by the quality of its scientific research and the care we put into each study. Excelra shares these values and brings broader expertise in data science and scientific computing, allowing us to do more for the researchers we work with."

Jannick Bendtsen, who serves as Vice President of Bioinformatics at Excelra, highlighted that Fios is well-known for delivering rigorous study-level analytics efficiently and clearly, exactly what researchers need when faced with a new dataset. He emphasized that this collaborative approach aligns seamlessly with Excelra's commitment to multi-omics integration, translational understanding, and scientific AI. The newly integrated team now has access to Excelra's rich datasets, AI engineering expertise, and a significantly larger pool of domain experts.

Anandbir Singh Brar, CEO of Excelra, expressed his excitement about welcoming the Fios team, stating, "Fios has built a team of bioinformaticians that clients trust for their toughest questions. With the combination of Fios' scientific expertise and our own bioinformatics capabilities, along with our data and in-built AI engineering, we can respond to these questions even faster and with greater confidence. The volume of omic data is continuously growing, but the fundamental questions remain—what target? what indication? which patients?"

The integration aims to not only enhance the analytical capabilities available to Fios's customers but also enrich the synergy between scientific inquiry and practical application. As the scientific community increasingly demands robust and timely insights from omic analyses, the collaboration aims to position both Excelra and the former Fios team at the forefront of this evolving market landscape.

Fios Genomics was founded in 2008 as a spin-off from the University of Edinburgh and has been instrumental in providing bioinformatics analyses and biological interpretation in genomic, transcriptomic, and multi-omic studies to global researchers in the pharmaceutical, biotech, and life sciences sectors.

As both companies embark on this joint journey, stakeholders can expect enhanced offerings and innovative solutions. Clients previously associated with Fios can still reach the team at the same email address: [email protected].

Excelra thrives on AI-driven R&D, combining AI-ready data and platforms such as GOSTAR, connected laboratory computing, and multi-omics expertise to transform R&D complexities into defensible decisions. They are guided by science, leveraging data while maintaining a focus on impactful outcomes.